title: Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?
authors.affiliation: Nuclear Medicine Division, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy. direzione.mnu@ieo.it
authors.forename: Giovanni
authors.initials: G
authors.lastname: Paganelli
authors.forename: Marco
authors.initials: M
authors.lastname: Chinol
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001360:Avidin / Q000627:therapeutic use*; D001710:Biotin / Q000627:therapeutic use*; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy / Q000379:methods*; D011878:Radiotherapy / Q000379:methods*
chemical_list: D000911:Antibodies, Monoclonal; D001360:Avidin; D001710:Biotin